Growth Metrics

Bio-Techne (TECH) Cash from Financing Activities (2009 - 2026)

Bio-Techne's quarterly Cash from Financing Activities came in at -$42.7 million in Q1 2026, up 37.22% year-on-year from -$31.1 million in Q1 2025, and up 12.8% quarter-over-quarter from -$49.0 million in Q4 2025.

Bio-Techne has reported Cash from Financing Activities for 18 years, with the latest figure at -$42.7 million in Q1 2026.

  • For the quarter ending Q1 2026, Cash from Financing Activities rose 37.22% year-over-year to -$42.7 million; the trailing twelve-month figure through Mar 2026 stood at -$226.4 million (down 1.26% YoY), and the FY2025 full-year result was -$253.9 million, down 107.44% from the prior year.
  • Cash from Financing Activities for Q1 2026 stood at -$42.7 million, up from -$49.0 million in the prior quarter.
  • The five-year high for Cash from Financing Activities was $150.8 million in Q1 2023, with the low at -$90.5 million in Q2 2025.
  • Average Cash from Financing Activities over 5 years is -$37.6 million, with a median of -$52.4 million recorded in 2024.
  • Year-over-year, Cash from Financing Activities soared 324.84% in 2023 and sank 282.02% in 2025.
  • Tracing TECH's Cash from Financing Activities over 5 years: stood at -$72.2 million in 2022, then decreased by 12.75% to -$81.4 million in 2023, then decreased by 3.0% to -$83.8 million in 2024, then soared by 41.57% to -$49.0 million in 2025, then advanced by 12.8% to -$42.7 million in 2026.
  • The last three Cash from Financing Activities figures came in at -$42.7 million (Q1 2026), -$49.0 million (Q4 2025), and -$44.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 7.00 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -600,000.00
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 53,000.00
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -538.80 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -802.20 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 15.71 Mn
10 Bio-Techne 7.92 Bn 7.71 Bn 208.29 Mn -42.72 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -42.72 Mn
Mar 31, 2026 -42.72 Mn
Dec 31, 2025 -48.99 Mn
Dec 31, 2025 -48.99 Mn
Sep 30, 2025 -44.20 Mn
Sep 30, 2025 -44.20 Mn
Jun 30, 2025 -90.45 Mn
Jun 30, 2025 -90.45 Mn
Mar 31, 2025 -68.05 Mn
Mar 31, 2025 -68.05 Mn
Dec 31, 2024 -83.84 Mn
Dec 31, 2024 -83.84 Mn
Sep 30, 2024 -11.57 Mn
Sep 30, 2024 -11.57 Mn
Jun 30, 2024 -60.10 Mn
Jun 30, 2024 -60.10 Mn
Mar 31, 2024 -52.42 Mn
Mar 31, 2024 -52.42 Mn
Dec 31, 2023 -81.40 Mn
Dec 31, 2023 -81.40 Mn
Sep 30, 2023 71.51 Mn
Sep 30, 2023 71.51 Mn
Jun 30, 2023 -24.22 Mn
Jun 30, 2023 -24.22 Mn
Mar 31, 2023 150.84 Mn
Mar 31, 2023 150.84 Mn
Dec 31, 2022 -72.20 Mn
Dec 31, 2022 -72.20 Mn
Sep 30, 2022 -31.81 Mn
Sep 30, 2022 -31.81 Mn
Jun 30, 2022 -65.73 Mn
Jun 30, 2022 -65.73 Mn
Mar 31, 2022 -84.07 Mn
Mar 31, 2022 -84.07 Mn
Dec 31, 2021 -53.38 Mn
Dec 31, 2021 -53.38 Mn
Sep 30, 2021 -39.68 Mn
Sep 30, 2021 -39.68 Mn
Jun 30, 2021 117.69 Mn
Jun 30, 2021 117.69 Mn
Mar 31, 2021 -55.23 Mn
Mar 31, 2021 -55.23 Mn
Dec 31, 2020 -90.08 Mn
Dec 31, 2020 -90.08 Mn
Sep 30, 2020 -34.93 Mn
Sep 30, 2020 -34.93 Mn
Jun 30, 2020 -44.72 Mn
Jun 30, 2020 -44.72 Mn
Mar 31, 2020 -17.79 Mn
Mar 31, 2020 -17.79 Mn
Dec 31, 2019 -97.03 Mn
Dec 31, 2019 -97.03 Mn
Sep 30, 2019 -24.27 Mn
Sep 30, 2019 -24.27 Mn
Jun 30, 2019 -19.90 Mn
Jun 30, 2019 -19.90 Mn
Mar 31, 2019 -27.04 Mn
Mar 31, 2019 -27.04 Mn
Dec 31, 2018 -41.21 Mn
Dec 31, 2018 -41.21 Mn
Sep 30, 2018 222.53 Mn
Sep 30, 2018 222.53 Mn
Jun 30, 2018 -62.83 Mn
Jun 30, 2018 -62.83 Mn
Mar 31, 2018 -952,000.00
Mar 31, 2018 -952,000.00
Dec 31, 2017 15.55 Mn
Dec 31, 2017 15.55 Mn
Sep 30, 2017 -50.95 Mn
Sep 30, 2017 -50.95 Mn
Jun 30, 2017 -16.65 Mn
Jun 30, 2017 -16.65 Mn
Mar 31, 2017 -24.52 Mn
Mar 31, 2017 -24.52 Mn
Dec 31, 2016 -11.89 Mn
Dec 31, 2016 -11.89 Mn
Sep 30, 2016 242.33 Mn
Sep 30, 2016 242.33 Mn
Jun 30, 2016 -32.33 Mn
Jun 30, 2016 -32.33 Mn
Mar 31, 2016 -19.54 Mn
Mar 31, 2016 -19.54 Mn
Dec 31, 2015 -13.37 Mn
Dec 31, 2015 -13.37 Mn
Sep 30, 2015 41.87 Mn
Sep 30, 2015 41.87 Mn
Jun 30, 2015 -85.68 Mn
Jun 30, 2015 -85.68 Mn
Mar 31, 2015 -11.00 Mn
Mar 31, 2015 -11.00 Mn
Dec 31, 2014 25.48 Mn
Dec 31, 2014 25.48 Mn
Sep 30, 2014 102.47 Mn
Sep 30, 2014 102.47 Mn
Jun 30, 2014 -8.01 Mn
Jun 30, 2014 -8.01 Mn
Mar 31, 2014 -9.91 Mn
Mar 31, 2014 -9.91 Mn
Dec 31, 2013 -8.98 Mn
Dec 31, 2013 -8.98 Mn
Sep 30, 2013 -9.90 Mn
Sep 30, 2013 -9.90 Mn
Jun 30, 2013 -12.58 Mn
Jun 30, 2013 -12.58 Mn
Mar 31, 2013 -11.05 Mn
Mar 31, 2013 -11.05 Mn
Dec 31, 2012 -10.30 Mn
Dec 31, 2012 -10.30 Mn
Sep 30, 2012 -10.75 Mn
Sep 30, 2012 -10.75 Mn
Jun 30, 2012 -12.45 Mn
Jun 30, 2012 -12.45 Mn
Mar 31, 2012 -13.20 Mn
Mar 31, 2012 -13.20 Mn
Dec 31, 2011 -17.43 Mn
Dec 31, 2011 -17.43 Mn
Sep 30, 2011 -21.56 Mn
Sep 30, 2011 -21.56 Mn
Jun 30, 2011 -8.24 Mn
Jun 30, 2011 -8.24 Mn
Mar 31, 2011 -10.02 Mn
Mar 31, 2011 -10.02 Mn
Dec 31, 2010 -7.12 Mn
Dec 31, 2010 -7.12 Mn
Sep 30, 2010 -10.91 Mn
Sep 30, 2010 -10.91 Mn
Jun 30, 2010 -23.03 Mn
Jun 30, 2010 -23.03 Mn
Mar 31, 2010 -8.57 Mn
Mar 31, 2010 -8.57 Mn
Dec 31, 2009 -9.03 Mn
Dec 31, 2009 -9.03 Mn
Sep 30, 2009 -9.89 Mn
Sep 30, 2009 -9.89 Mn